Presentation is loading. Please wait.

Presentation is loading. Please wait.

Date of download: 7/16/2016 Copyright © The American College of Cardiology. All rights reserved. From: Vena Caval Filter Utilization and Outcomes in Pulmonary.

Similar presentations


Presentation on theme: "Date of download: 7/16/2016 Copyright © The American College of Cardiology. All rights reserved. From: Vena Caval Filter Utilization and Outcomes in Pulmonary."— Presentation transcript:

1 Date of download: 7/16/2016 Copyright © The American College of Cardiology. All rights reserved. From: Vena Caval Filter Utilization and Outcomes in Pulmonary Embolism: Medicare Hospitalizations From 1999 to 2010 J Am Coll Cardiol. 2016;67(9):1027-1035. doi:10.1016/j.jacc.2015.12.028 Proportion of Medicare Fee-for-Service Patients With Pulmonary Embolism With and Without Inferior Vena Caval Filter Placement in 1999 and 2010 Shown are the number of patients with pulmonary embolism (PE), those who received inferior vena caval filters (IVCFs), and the fatalities in those who did and did not receive IVCFs. The size of each rectangle is proportionate to the number of patients in each subgroup. Note that the number of deaths in the entire cohort, as well as among those with and without IVCFs, increased from 1999 to 2010. However, in the context of increasing PE hospitalizations (denominator), the mortality rates declined in all cohorts, with the most notable decline in the subgroup that did not receive IVCFs. The fatalities in the figure represent 30-day unadjusted deaths. Adjusted 30-day and 1-year fatalities follow a similar pattern. Figure Legend:

2 Date of download: 7/16/2016 Copyright © The American College of Cardiology. All rights reserved. From: Vena Caval Filter Utilization and Outcomes in Pulmonary Embolism: Medicare Hospitalizations From 1999 to 2010 J Am Coll Cardiol. 2016;67(9):1027-1035. doi:10.1016/j.jacc.2015.12.028 Rates of Inferior Vena Caval Filter Placement Across 9 U.S. Regions in 1999 and 2010 Note the changes in 2010 compared with 1999, including the decline in New England and the increases in most other regions. Rates are reported per 1,000 patients with pulmonary embolism. South Atlantic: Delaware, Florida, Georgia, Maryland, North Carolina, South Carolina, Virginia, Washington, D.C., and West Virginia. New England: Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, and Vermont. Mid-Atlantic: New Jersey, New York, and Pennsylvania. East North Central: Illinois, Indiana, Michigan, Ohio, and Wisconsin. East South Central: Alabama, Kentucky, Mississippi, and Tennessee. West South Central: Arkansas, Louisiana, Oklahoma, and Texas. Pacific: Alaska, California, Hawaii, Oregon, and Washington. West North Central: Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, and South Dakota. Mountain: Arizona, Colorado, Idaho, Montana, Nevada, New Mexico, Utah, and Wyoming. Figure Legend:

3 Date of download: 7/16/2016 Copyright © The American College of Cardiology. All rights reserved. From: Vena Caval Filter Utilization and Outcomes in Pulmonary Embolism: Medicare Hospitalizations From 1999 to 2010 J Am Coll Cardiol. 2016;67(9):1027-1035. doi:10.1016/j.jacc.2015.12.028 Inferior Vena Caval Filters in Older Adults With Pulmonary Embolism: Mortality and Hospitalization Rates From 1999 to 2010 Solid lines show hospitalization rates for PE, hospitalizations with PE in which patients received an IVCF in the Medicare FFS population, and also IVCF utilization per 1,000 PE hospitalizations. Dashed lines represent mortality rates in the entire PE cohort, and the subgroup who received IVCFs. Hospitalizations for PE and use of IVCFs in the Medicare FFS have both increased over time, leading to stable IVCF utilization rates for PE hospitalizations over time. Mortality rates have declined among patients with PE, including those using IVCFs. FFS = fee-for-service; IVCF = inferior vena caval filter; PE = pulmonary embolism. Figure Legend:


Download ppt "Date of download: 7/16/2016 Copyright © The American College of Cardiology. All rights reserved. From: Vena Caval Filter Utilization and Outcomes in Pulmonary."

Similar presentations


Ads by Google